Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led viral vector CDMO, today announces that it will host a webinar on the ...
Oxford, UK – 23 January 2024: On Wednesday 7 February, Oxford Biomedica, a quality and innovation-led cell and gene therapy CDMO, will host a free 60-minute webinar offering an in-depth view of the ...
The content highlighted in this article has been created and hosted by Physics World’s corporate partners. It is free to read but you will be asked to share your contact details with the relevant ...
OXFORD, UK and CLEVELAND, Ohio, US, February 27 th, 2024 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at ...
Cell and gene therapies are rapidly becoming a staple of the therapeutic landscape for a range of diseases. Recent improvements in the accuracy, read length, and throughput offered by Oxford Nanopore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results